Related Experiment Video
Updated: May 29, 2025

Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
Circular RNAs in cancer
Yang Guo1, Qiang Huang1, Yu Heng1
1ENT Institute and Department of Otorhinolaryngology Eye & ENT Hospital, Fudan University Xuhui District Shanghai China.
Abstract:
Circular RNA (circRNA), a subtype of noncoding RNA, has emerged as a significant focus in RNA research due to its distinctive covalently closed loop structure. CircRNAs play pivotal roles in diverse physiological and pathological processes, functioning through mechanisms such as miRNAs or proteins sponging, regulation of splicing and gene expression, and serving as translation templates, particularly in the context of various cancers. The hallmarks of cancer comprise functional capabilities acquired during carcinogenesis and tumor progression, providing a conceptual framework that elucidates the nature of the malignant transformation. Although numerous studies have elucidated the role of circRNAs in the hallmarks of cancers, their functions in the development of chemoradiotherapy resistance remain unexplored and the clinical applications of circRNA-based translational therapeutics are still in their infancy. This review provides a comprehensive overview of circRNAs, covering their biogenesis, unique characteristics, functions, and turnover mechanisms. We also summarize the involvement of circRNAs in cancer hallmarks and their clinical relevance as biomarkers and therapeutic targets, especially in thyroid cancer (TC). Considering the potential of circRNAs as biomarkers and the fascination of circRNA-based therapeutics, the "Ying-Yang" dynamic regulations of circRNAs in TC warrant vastly dedicated investigations.
Insights
Circular RNAs (circRNAs) are key in cancer, regulating its hallmarks. Further research into circRNA's role in thyroid cancer (TC) resistance to chemoradiotherapy is crucial for developing new treatments.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Circular RNAs (circRNAs) are noncoding RNAs with a unique structure.
- They play roles in physiological and pathological processes, including cancer.
- Their specific functions in chemoradiotherapy resistance and clinical applications are not fully understood.
Purpose of the Study:
- To provide a comprehensive overview of circRNAs.
- To summarize circRNA involvement in cancer hallmarks.
- To highlight circRNAs' potential as biomarkers and therapeutic targets in thyroid cancer (TC).
Main Methods:
- Literature review of circRNA biogenesis, characteristics, functions, and turnover.
- Analysis of circRNA roles in cancer hallmarks.
- Focus on circRNAs in thyroid cancer (TC) and chemoradiotherapy resistance.
Main Results:
- CircRNAs are involved in cancer hallmarks through various mechanisms.
- Their potential as biomarkers and therapeutic targets is significant.
- The "Ying-Yang" dynamic regulation of circRNAs in TC requires further investigation.
Conclusions:
- CircRNAs have diverse roles in cancer development and progression.
- CircRNAs show promise as biomarkers and therapeutic targets, particularly in thyroid cancer.
- More research is needed to explore circRNA functions in chemoradiotherapy resistance and clinical applications.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Ras Gene
Ras is a...
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

